8-K//Current report
AN2 Therapeutics, Inc. 8-K
Accession 0001193125-25-277662
$ANTXCIK 0001880438operating
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 11:19 AM ET
Size
387.0 KB
Accession
0001193125-25-277662
Documents
- 8-Kantx-20251112.htmPrimary
8-K
- EX-99.1antx-ex99_1.htm
EX-99.1
- EX-101.SCHantx-20251112.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-277662-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLantx-20251112_htm.xml
IDEA: XBRL DOCUMENT
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001880438
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 11:19 AM ET
- Size
- 387.0 KB